Clinical Trials Directory

Trials / Unknown

UnknownNCT04334005

Vitamin D on Prevention and Treatment of COVID-19

Effect of Vitamin D Administration on Prevention and Treatment of Mild Forms of Suspected Covid-19

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Universidad de Granada · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

The new outbreak of the SARS-CoV-2 coronavirus is causing an important pandemic affecting a large number of people all-over the world. Vitamin D is a hormone precursor produced by our own body with the help of sunlight which has an important role on adaptive immunity and cellular differentiation, maturation and proliferation of several immune cells. Reduced levels of vitamin D in calves were positioned as the main cause of bovine coronavirus infection in the past. Therefore, it seems plausible that the use of vitamin D as a nutritional ergogenic aid could be a potential intervention to fight against COVID-19 infected patients which remain asymptomatic or which have non-severe and severe symptoms. This study aims to investigate whether the use of vitamin D as an immune modulator agent induces significant improvements of health status and outcomes in non-severe symptomatic patients infected with COVID-19 as well as preventing COVID-19 health deterioration. We hypothesize that vitamin D will significantly improve hard endpoints related to COVID-19 deleterious consequences compared with a usual care control group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin DThe intervention group will receive a single dose of 25000 UI of vitamin D supplement in addition to prescription of NSAIDs, ACE2 inhibitor, ARB or thiazolidinediones, according to clinician criteria, based on the current recommendations. Vitamin D supplementation will be taken in the morning together with a toast with olive oil to facilitate its absorption.

Timeline

Start date
2020-04-10
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2020-04-03
Last updated
2020-04-07

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04334005. Inclusion in this directory is not an endorsement.